3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Diseases
1
Neoplasms by Site
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
Bevacizumab
3
napabucasin
2
Leucovorin
2
Irinotecan
2
Gemcitabine
2
Fluorouracil
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
trifluridine tipiracil drug combination
1
linifanib
1
enoxaparin sodium
1
encorafenib
1
Surveys and Questionnaires
1
Sorafenib
1
Oxaliplatin
1
Oviposition
1
Levoleucovorin
1
Injections
1
Hydromorphone
1
Fentanyl
1
Drug Therapy
1
Drainage
1
Dalteparin
1
Cetuximab
1
Capecitabine
1
Bupivacaine
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Digestive System Diseases
×
Drainage
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled